These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 8418225

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The efficacy of octreotide in the therapy of acute radiation-induced diarrhea: a randomized controlled study.
    Yavuz MN, Yavuz AA, Aydin F, Can G, Kavgaci H.
    Int J Radiat Oncol Biol Phys; 2002 Sep 01; 54(1):195-202. PubMed ID: 12182992
    [Abstract] [Full Text] [Related]

  • 3. Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma.
    Topkan E, Karaoglu A.
    Oncology; 2006 Sep 01; 71(5-6):354-60. PubMed ID: 17873499
    [Abstract] [Full Text] [Related]

  • 4. Control of chemotherapy-induced diarrhoea with octreotide in patients receiving 5-fluorouracil.
    Cascinu S, Fedeli A, Fedeli SL, Catalano G.
    Eur J Cancer; 1992 Sep 01; 28(2-3):482-3. PubMed ID: 1591068
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Octreotide therapy of large-volume refractory AIDS-associated diarrhea: a randomized controlled trial.
    Garcia Compean D, Ramos Jimenez J, Guzman de la Garza F, Saenz C, Maldonado H, Barragan RF, Michel H.
    AIDS; 1994 Nov 01; 8(11):1563-7. PubMed ID: 7848592
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High-dose loperamide in the treatment of 5-fluorouracil-induced diarrhea in colorectal cancer patients.
    Cascinu S, Bichisao E, Amadori D, Silingardi V, Giordani P, Sansoni E, Luppi G, Catalano V, Agostinelli R, Catalano G.
    Support Care Cancer; 2000 Jan 01; 8(1):65-7. PubMed ID: 10650901
    [Abstract] [Full Text] [Related]

  • 11. Control of irinotecan-induced diarrhea by octreotide after loperamide failure.
    Barbounis V, Koumakis G, Vassilomanolakis M, Demiri M, Efremidis AP.
    Support Care Cancer; 2001 Jun 01; 9(4):258-60. PubMed ID: 11430421
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Multicenter, double-blind, randomized comparison of wood creosote, the principal active ingredient of Seirogan, an herbal antidiarrheal medication, and loperamide in adults with acute nonspecific diarrhea.
    Kuge T, Shibata T, Willett MS.
    Clin Ther; 2004 Oct 01; 26(10):1644-51. PubMed ID: 15598481
    [Abstract] [Full Text] [Related]

  • 14. Resolution of refractory chemotherapy-induced diarrhea (CID) with octreotide long-acting formulation in cancer patients: 11 case studies.
    Rosenoff S.
    Support Care Cancer; 2004 Aug 01; 12(8):561-70. PubMed ID: 15160318
    [Abstract] [Full Text] [Related]

  • 15. Randomized trial of loperamide versus dose escalation of octreotide acetate for chemotherapy-induced diarrhea in bone marrow transplant and leukemia patients.
    Geller RB, Gilmore CE, Dix SP, Lin LS, Topping DL, Davidson TG, Holland HK, Wingard JR.
    Am J Hematol; 1995 Nov 01; 50(3):167-72. PubMed ID: 7485077
    [Abstract] [Full Text] [Related]

  • 16. Octreotide LAR resolves severe chemotherapy-induced diarrhoea (CID) and allows continuation of full-dose therapy.
    Rosenoff SH.
    Eur J Cancer Care (Engl); 2004 Sep 01; 13(4):380-3. PubMed ID: 15305907
    [Abstract] [Full Text] [Related]

  • 17. Octreotide Acetate in the Treatment of Fluorouracil-Induced Diarrhea.
    Goumas P, Naxakis S, Christopoulou A, Chrysanthopoulos C, Nikolopoulou V, Kalofonos HP.
    Oncologist; 1998 Sep 01; 3(1):50-53. PubMed ID: 10388084
    [Abstract] [Full Text] [Related]

  • 18. Octreotide for symptomatic treatment of diarrhea due to cytomegalovirus colitis.
    Bartels MC, Mergenhagen KA.
    Ann Pharmacother; 2011 Jan 01; 45(1):e4. PubMed ID: 21189368
    [Abstract] [Full Text] [Related]

  • 19. [Management of chemotherapy induced diarrhea].
    Schultz M, Schölmerich J, Kullmann F.
    Z Gastroenterol; 2004 Jun 01; 42(6):527-38. PubMed ID: 15190449
    [Abstract] [Full Text] [Related]

  • 20. Phase II/pharmacodynamic trial of dose-intensive, weekly parenteral hydroxyurea and fluorouracil administered with interferon alfa-2a in patients with refractory malignancies of the gastrointestinal tract.
    Wadler S, Damle S, Haynes H, Kaleya R, Schechner R, Berkenblit R, Ladner RD, Murgo A.
    J Clin Oncol; 1999 Jun 01; 17(6):1771-8. PubMed ID: 10561214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.